Development and validation of a highly sensitive and selective LC-MS/MS method for the determination of 15-hydroxylubiprostone in human plasma: application to a pharmacokinetic study in healthy Chinese volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and validation of a highly sensitive and selective LC-MS/MS method for the determination of 15-hydroxylubiprostone in human plasma: application to a pharmacokinetic study in healthy Chinese volunteers

Published:2022-06-03 Issue:6 Volume:52 Page:567-574
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Li Xianjing¹²,Yu Haitao³,Guo Wenjing¹²,Cheng Minlu⁴,Song Qinxin¹²,Ding Li¹²⁴

Affiliation:

1. Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, Nanjing, China

2. Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China

3. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd, Nanjing, China

4. Nanjing Clinical Tech. Laboratories Inc, Nanjing, China

Funder

National Natural Science Foundation of China

Jiangsu Provincial Natural Science Foundation

Open Project Program of MOE Key Laboratory of Drug Quality Control and Pharmacovigilance

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2022.2123751

Reference24 articles.

1. Irritable Bowel Syndrome

2. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management

3. Short Chain Fatty Acids Effect on Chloride Channel ClC-2 as a Possible Mechanism for Lubiprostone Intestinal Action

4. SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents

5. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Bioequivalence of the Lubiprostone Capsule in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2023-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3